Nematocidal activity of chitosan nanoparticles conjugated with albendazole against the enteral and parenteral phases of trichinosis in experimentally infected mice

被引：1
作者：
Mahgoub A.A. [1 ]
Shoieb R.M. [2 ]
Negm M.S. [3 ]
Ibrahim H.M. [4 ]
El-Sayed S.H. [2 ]
Khater M.M. [1 ]
机构：
[1] Medical Parasitology Department, Faculty of Medicine, Kasr Al-Ainy, Cairo University, Cairo
[2] Medical Parasitology Department, Faculty of Medicine, Helwan University, Cairo
[3] Pathology Department, Faculty of Medicine, Cairo University, Cairo
[4] Textile Research Division, National Research Centre, Cairo
来源：
Journal of Parasitic Diseases | 2024年 / 48卷 / 1期
关键词：
Albendazole; Chitosan nanoparticles; Histopathological examination; Murine infection; Parasitological; Trichinella spiralis;
D O I：
10.1007/s12639-024-01648-4
中图分类号：
学科分类号：
摘要：
Trichinosis is a serious parasitic zoonotic disease caused mainly by Trichinella spiralis. The used drugs for treatment of trichinosis showed limited bioavailability and high degree of resistance. Moreover, they have a very poor effect in treatment of encysted larvae. Therefore, there is a need for development of new agents which help in improving the bioavailability of the used drugs and enable them to reach different tissues. This study was designed to assess the use of chitosan nanoparticles (CSNPs) in conjugation with full and half dose albendazole (ABZ) in treatment of intestinal and muscular trichinosis. Albino mice (84 mice) were used to evaluate the efficacy of drugs and divided into seven groups; I: control, II: ABZ (50 mg/kg) treated, III: ABZ (25 mg/kg) treated, IV: ABZ (50 mg/kg) conjugated CSNPs treated, V: ABZ (25 mg/kg) conjugated CSNPs treated, VI: CS treated and VII: CSNPs treated. Parasitological and histopathological examinations were used to evaluate the therapeutic efficacy of the used drugs. Results showed significant reduction of adult Trichinella extracted from intestine of all ABZ treated groups either conjugated or not with the highest reduction rate in group IV followed by group V with percentage of reduction of 99.33% and 98.11%, respectively and marked improvement of histopathological examination. Also, results showed significant reduction of Trichinella larvae extracted from muscles of group IV, V and VII with the highest reduction rate in group IV with percentage of reduction of 100% in muscle larvae and marked improvement of histopathological examination. It was concluded that albendazole full dose conjugated chitosan nanoparticles can be a good candidate drug for treating both intestinal and muscular trichinosis. © Indian Society for Parasitology 2024.
引用
收藏
页码：141 / 149
页数：8
相关论文
共 40 条
  • [1] Arundel J.H., Boersema J.H., Bruyning C.F.A., Cross J.H., Davis A., de Muynck A., Kammerer W.S., Michel J.F., Mirck M.H., Rickard M.D., Rochette F., Chemotherapy of gastrointestinal helminths, 77, (2012)
  • [2] Ashour D.S., Rayia D.M.A., Saad A.E., El-Bakary R.H., Nitazoxanide anthelmintic activity against the enteral and parenteral phases of trichinellosis in experimentally infected rats, Exp Parasitol, 170, pp. 28-35, (2016)
  • [3] Attia R.A., Mahmoud A.E., Farrag H.M.M., Makboul R., Mohamed M.E., Ibraheim Z., Effect of myrrh and thyme on Trichinella spiralis enteral and parenteral phases with inducible nitric oxide expression in mice, Mem Inst Oswaldo Cruz, 110, 8, pp. 1035-1041, (2015)
  • [4] Aziz M.A., Cabral J.D., Brooks H.J., Moratti S.C., Hanton L.R., Antimicrobial properties of a chitosan dextran-based hydrogel for surgical use, Antimicrob Agents Chemother, 56, 1, pp. 280-287, (2012)
  • [5] Barrera M.G., Leonardi D., Bolmaro R.E., Echenique C.G., Olivieri A.C., Salomon C.J., Lamas M.C., In vivo evaluation of albendazole microspheres for the treatment of Toxocara canis larva migrans, Eur J Pharm Biopharm, 75, 3, pp. 451-454, (2010)
  • [6] Basyoni M.M., El-Sabaa A.A.A., Therapeutic potential of myrrh and ivermectin against experimental Trichinella spiralis infection in mice, Korean J Parasitol, 51, 3, (2013)
  • [7] Bruschi F., Dupouy-Camet J., Trichinellosis, Helminth Infections and Their Impact on Global Public Health, pp. 229-273, (2014)
  • [8] Bruschi F., Murrell K.D., Trichinellosis. In Hunter's tropical medicine and emerging infectious diseases, pp. 882-884, (2020)
  • [9] Chung M.S., Joo K.H., Quan F.S., Kwon H.S., Cho S.W., Efficacy of flubendazole and albendazole against Trichinella spiralis in mice, Parasite, 8, pp. S195-S198, (2001)
  • [10] Codina A.V., Garcia A., Leonardi D., Vasconi M.D., Di Masso R.J., Lamas M.C., Hinrichsen L.I., Efficacy of albendazole: β-cyclodextrin citrate in the parenteral stage of Trichinella spiralis infection, Int J Biol Macromol, 77, pp. 203-206, (2015)
1234